Hutch News
Results per Page:
Wild-type vs. modification: which is better?
From Stamatatos Laboratory, Vaccine and Infectious Disease Division
To protect, or to enhance? That is the question for Dengue virus antibodies
From Dr. Halloran, Vaccine and Infectious Disease Division
Thai HIV vaccine trial follow-up studies offer possible explanation for HIV prevention success
Peter Gilbert and SCHARP researchers, HVTN Laboratory Program, part of worldwide effort to understand trial outcome, influence future HIV vaccine studies
HIV 'superinfection' boosts immune response
Overbaugh, Cortez-led study shows women infected by two different HIV strains exhibit strong antibody response; findings may aid vaccine development
Study finds HIV ‘superinfection’ boosts immune response
Findings may provide insight into HIV-vaccine development
American Society for Microbiology lauds Blish
HIV research garners early career award
An 'HIV-test' equivalent for early detection of lung cancer
New cancer-screening strategy uses the immune system to signal early signs of disease
Antibody-Targeted Chemotherapy with Mylotarg Shows Promise for Many Adults with Deadly Form of Leukemia
Fred Hutchinson Cancer Research Center Researcher Presents Updated Study Results at the American Society of Clinical Oncology Meeting in New Orleans